Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sus Clinicals
Cincinnati, Ohio, United Statessusclinicals.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Sus Clinicals offers proprietary pig-based preclinical testing services using the Oncopig Cancer Model to accelerate qualification of cancer therapeutics. Their models have been shown to recapitulate human tumor responses to chemotherapeutic agents such as cisplatin, doxorubicin, and gemcitabine in vitro.[6] The company’s FDA-cleared protocols enable more predictive assessment of drugs and devices prior to human clinical trials.[7]
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologicDevice
- Industry
- Drug Discovery Services
02
Partnerships
University of Illinois (exclusive global licensee for OCM intellectual property)
Beyond the preview
Go deeper on Sus Clinicals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sus Clinicals.